Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20226 (
TATA-binding protein
)
1,297
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The transcriptional activator
E2F1
regulates the expression of genes at the G1/S boundary. We have characterized interactions of the
E2F1
activation domain with two general transcription factors, the
TATA-box binding protein
(
TBP
) and TFIIH. Two distinct binding sites on
E2F1
were identified for
TBP
(amino acids 386-417 and 415-437) each of which supported activation in mammalian cells when expressed as a fusion to a heterologous DNA-binding domain. Neither of these minimal activation domains independently bound TFIIH; rather, the TFIIH binding site of
E2F1
overlaps both domains. Loss of TFIIH-binding by
E2F1
resulted in a 60-65% reduction in transactivation, suggesting that the
E2F1
/TFIIH interaction is important, but not essential, for transactivation. The retinoblastoma protein (Rb) binds directly to
E2F1
and represses
E2F1
-mediated transactivation. We have demonstrated that recombinant Rb can compete with
TBP
and the p62 subunit of TFIIH for binding to immobilized
E2F1
. A tumorigenic form of Rb deficient in repressing
E2F1
-mediated transactivation is likewise deficient in displacing
TBP
from
E2F1
. We propose that competition between Rb and both
TBP
and TFIIH for binding to
E2F1
is a mechanism by which Rb inhibits transactivation by
E2F1
.
...
PMID:Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH. 940 Sep 91
The E2F family of heterodimeric transcription factors plays an important role in the regulation of gene expression at the G1/S phase transition of the mammalian cell cycle. Previously, we have demonstrated that cell cycle regulation of murine dihydrofolate reductase (dhfr) expression requires E2F-mediated activation of the dhfr promoter in S phase. To investigate the mechanism by which E2F activates an authentic E2F-regulated promoter, we precisely replaced the E2F binding site in the dhfr promoter with a Gal4 binding site. Using Gal4-
E2F1
derivatives, we found that
E2F1
amino acids 409-437 contain a potent core transactivation domain. Functional analysis of the
E2F1
core domain demonstrated that replacement of phenylalanine residues 413, 425, and 429 with alanine reduces both transcriptional activation of the dhfr promoter and protein-protein interactions with CBP, transcription factor (TF) IIH, and
TATA-binding protein
(
TBP
). However, additional amino acid substitutions for phenylalanine 429 demonstrated a strong correlation between activation of the dhfr promoter and binding of CBP, but not TFIIH or
TBP
. Finally, transactivator bypass experiments indicated that direct recruitment of CBP is sufficient for activation of the dhfr promoter. Therefore, we suggest that recruitment of CBP is one mechanism by which E2F activates the dhfr promoter.
...
PMID:Activation of the murine dihydrofolate reductase promoter by E2F1. A requirement for CBP recruitment. 1033 93
The heterodimeric
transcription factor E2F1
-DP1 plays crucial roles in coordinating gene expression during G
1
/S cell cycle progression. For transcriptional activation, the transactivation domain (TAD) of
E2F1
is known to interact with the
TATA-binding protein
of TFIID and the p62 subunit of TFIIH. It is generally believed that DP1 facilitates
E2F1
binding to target DNA and does not possess a TAD. Here, we show that an acidic region of DP1, whose function has remained elusive, binds to the plekstrin homology (PH) domain of p62 with higher affinity than that of
E2F1
and contributes to transcriptional activation. The structure of the complex revealed that DP1 forms a twisted U-shaped, string-like conformation and binds to the surface of the PH domain by anchoring Phe403 into a pocket in the PH domain. The transcriptional activity of
E2F1
-DP1 was reduced when Phe403 of DP1 was mutated. These findings indicate that the acidic region of DP1 acts as a TAD by contacting TFIIH.
...
PMID:The Interaction Mode of the Acidic Region of the Cell Cycle Transcription Factor DP1 with TFIIH. 2782 26